Filtering options
Advanced Analytics
Advanced Therapies
Biologics
Biometrics
Biopharma
BioRegion
Biostatistics
Biotech
Cardiology
CDMO
Clinical
Clinical Operations
Clinical Trials
CMC
Complex Innovative Design
CRO
Crowdfunding
Data Science
Decentralized Clinical Trials
Dermatology
Diabetes
Diagnostics
Digital Health
Digital Therapeutics
Digital Transformation
Diversity
Drug Development
Due Diligence
eCOA
Economic Policy
Environmental Policy
EU
European Medicines Agency
France
Funding
Genomic Testing
Health Economics
Health Policy
Healthcare Technology
HEOR
Hybrid Clinical Trials
In-Vitro Diagnostic Regulation
Innovation
Investor Relations
ISE/ISS
Italy
IVDR
Life Sciences
Lifecycle Optimization
M&A
Market Access
Market Trends
Medical Devices
Medical Robotics
MedTech
Mobile Tech
Oncology
Orphan Drug
Orthopedic
Outcomes Research
Outsourcing Clinical Trials
Patient Advocacy
Patient Centricity
Patient Engagement
Pharma
Press Release
Product Development
Rare Disease
Real-World Evidence (RWE)
Registry-based studies
Regulatory
Research & Development
Research and Development
RWE Decision Alert
Spain
Startups
Therapeutics
Transaction Advisory
UK
USA
Vaccines
Wound Healing
All
News
Latest from Alira Health
Execution: How Biotechs Can Plan and Run Successful Clinical Trials
Biotech experts Joris Pezzini and Chris Rao answer questions about the challenges of executing a successful clinical trial.
Mandatory Patient-Focused Listening Sessions with CMS: What Manufacturers Need to Know
To learn about patient-focused listening sessions, their potential impact, and how manufacturers can prepare, we spoke with our experts.
What EU Companies Need to Know about the U.S. Inflation Reduction Act
We spoke with our inhouse experts to learn about the significance of the US Inflation Reduction Act for EU pharma and biotech companies.
BioSpain
We are excited to attend, speak at, and sponsor BioSpain, one of the leading conferences in the European biotechnology field.
12th EPP Life Sciences Pricing Forum
We are excited to speak at the 12th EPP Life Sciences Pricing Forum for pricing directors and executives in Life Sciences.
European Statistical Forum
We'll be at European Statistical Forum to discuss how to optimize sample sizes and time to decision using innovative trial designs.
Webinar on Advancing Patient Engagement in the Medical Device / MedTech Industry
Engaging with patients, including their caregivers and advocates, is crucial during the planning and execution of clinical trials.
How to Increase Patient Engagement in Your Clinical Trials
Engaging with patients, including their caregivers and advocates, is crucial during the planning and execution of clinical trials.
MedTech CDMO: Market and M&A Trends in the U.S. in 2023
Review current trends shaping the US medical device outsourcing landscape, its performance and business outlook, and sustained M&A activity.
Manufacturing Challenges of Therapeutic Antibody-Drug Conjugates
Our expert CMC team addresses the manufacturing challenges of ADCs in “Manufacturing Challenges of Therapeutic Antibody-Drug Conjugates.”
UK HTA Approves TRANSLARNA (Ataluren) for Duchenne Muscular Dystrophy Citing Real-World Evidence
The NICE recommended routine funding for TRANSLARNA (ataluren) to treat Duchenne Muscular Dystrophy (DMD), based on RWE combined with feedback from patients, caregivers, and clinicians.
Opportunities and Challenges in the Therapeutic and CDMO Markets
Our Transaction Advisory experts have analyzed the CDMO industry trends, M&A activities, and projected growth in this CHEManager article.
Subscribe to our newsletter for the latest news, events, and thought leadership